“…25 Measurement of SFMC has been reported to be useful not only for the diagnosis, but also for deciding therapy for patients with DIC, pre-DIC, deep vein thrombosis, pulmonary embolism, and multiple organ failure. [26][27][28][29] Further, the SFMC assay was reported to be a promising method for determining in vivo fibrin formation in patients with acute myocardial infarction, irrespective of whether the primary treatment was fibrinolytic therapy or acute percutaneous coronary angioplasty. 30 Many parameters, such as fibrinopeptide A, prothrombin fragment 1 + 2, TAT, and d-dimer are presently used in the diagnosis of DIC.…”